MOZ–TIF2-mediated destruction of CBP/p300 is blocked by calpain inhibitor 2

Abstract

22: 1679–1689. 8 Fierro F, Illmer T, Jing D, Schleyer E, Ehninger G, Boxberger S et al. Inhibition of platelet-derived growth factor receptor beta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro. Cell Prolif 2007; 40: 355–366. 9 Gazzerro E, Canalis E. Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 2006; 7: 51–65. 10 Mariani S, Giona F, Basciani S, Brama M, Gnessi L. Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty. Lancet 2008; 372: 111–112. 11 Khoury HJ, Guilhot F, Hughes TP, Kim DW, Cortes JE. Dasatinib treatment for Philadelphia chromosome-positive leukemias: practical considerations. Cancer 2009; 115: 1381–1394. 12 Giles FJ, O’Dwyer M, Swords R. Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia. Leukemia 2009; 23: 1698–1707. 13 Li B, Boast S, de los SK, Schieren I, Quiroz M, Teitelbaum SL et al. Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat Genet 2000; 24: 304–308. 14 Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 2006; 4: 111–121. 15 Martin TJ, Allan EH, Ho PW, Gooi JH, Quinn JM, Gillespie MT et al. Communication between EphrinB2 and EphB4 within the osteoblast lineage. Adv Exp Med Biol 2010; 658: 51–60. 16 Tokunaga A, Oya T, Ishii Y, Motomura H, Nakamura C, Ishizawa S et al. PDGF receptor beta is a potent regulator of mesenchymal stromal cell function. J Bone Mine Res 2008; 23: 1519–1528. 17 Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S et al. Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol 2000; 151: 311–320. 18 Wildes TM, Procknow E, Gao F, Dipersio JF, Vij R. Dasatinib in relapsed or plateau-phase multiple myeloma. Leuk Lymphoma 2009; 50: 137–140.

DOI: 10.1038/leu.2010.92

Cite this paper

@article{Kindle2010MOZTIF2mediatedDO, title={MOZ–TIF2-mediated destruction of CBP/p300 is blocked by calpain inhibitor 2}, author={Karin B. Kindle and Harry M. Collins and David M. Heery}, journal={Leukemia}, year={2010}, volume={24}, pages={1359-1361} }